We are encouraging SMEs addressing challenges related to COVID-19 to apply for funding support offered by DIGI-B-CUBE open call
The COVID-19 pandemic represents an unprecedented challenge for healthcare systems and societies worldwide. There is an urgent need for novel diagnostics solutions, integrated detection systems and biosensing technologies that would, in a rapid, specific and efficient way, support the identification and tracking of infection chains and acquired immunity. Biological and biomedical imaging technologies are also essential for addressing many research questions, such as those related to SARS-CoV-2 infections, from basic research at the molecular and cellular level to medical applications and diagnostics. In addition, Biobanking processes are crucial in the race towards a COVID-19 vaccine and development of treatment options.
There is an urgent need to support Small and Medium-sized Enterprises (SMEs) capable of delivering innovation projects addressing the broad range of COVID-19 related challenges.
Through DIGI-B-CUBE project, we are announcing our funding support for SMEs to fight against COVID-19 through cross-sectoral collaborative projects. DIGI-B-CUBE offers direct financial support up to €60,000 per SME from relevant sectors including healthcare, medicine, biotech, biopharma, IT, robotics, automation, electronics, and nanotech. DIGI-B-CUBE supports digital innovations and solutions for the reconfiguration of the Medical Diagnostics and related value chains (depicted in the diagram below) towards a Health Economy 4.0 with a special focus on Biobanking, Bioimaging, Biosensing and related industries.
More info: HERE
English
Croatian
Czech
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hungarian
Irish
Italian
Latvian
Lithuanian
Luxembourgish
Maltese
Norwegian
Polish
Portuguese
Slovenian
Spanish
Show Comments